The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
5‐Fluorouracil Encapsulated Chitosan Nanoparticles for pH‐Stimulated Drug Delivery: Evaluation of Controlled Release Kinetics
Open accessAbstract
Nanoparticles consisting of human therapeutic drugs are suggested as a promising strategy for targeted and localized drug delivery to tumor cells. In this study, 5‐fluorouracil (5‐FU) encapsulated chitosan nanoparticles were prepared in order to investigate potentials of localized drug delivery for tumor environment due to pH sensitivity of chitosan nanoparticles. Optimization of chitosan and 5‐FU encapsulated nanoparticles production revealed 148.8 ± 1.1 nm and 243.1 ± 17.9 nm particle size diameters with narrow size distributions, which are confirmed by scanning electron microscope (SEM) images. The challenge was to investigate drug delivery of 5‐FU encapsulated chitosan nanoparticles due to varied pH changes. To achieve this objective, pH sensitivity of prepared chitosan nanoparticle was evaluated and results showed a significant swelling response for pH 5 with particle diameter of ~450 nm. In vitro release studies indicated a controlled and sustained release of 5‐FU from chitosan nanoparticles with the release amounts of 29.1–60.8% due to varied pH environments after 408 h of the incubation period. pH sensitivity is confirmed by mathematical modeling of release kinetics since chitosan nanoparticles showed stimuli‐induced release. Results suggested that 5‐FU encapsulated chitosan nanoparticles can be launched as pH‐responsive smart drug delivery agents for possible applications of cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of solute release from porous hydrophilic polymers
Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90064-9 · Cited by 5,258
Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600521210 · Cited by 4,884
Investigative Ophthalmology and Visual Science
Frey, C. (2010) · Cited by 3,350
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Hydrogel nanoparticles in drug delivery
Hamidi, M., Azadi, A., & Rafiei, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.002 · Cited by 2,067
Preparation and antibacterial activity of chitosan nanoparticles
Qi, L., Xu, Z., Jiang, X., Hu, C., & Zou, X. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.09.007 · Cited by 1,804
Gee, G. (1972) · Polymer · doi:10.1016/0032-3861(72)90025-0 · Cited by 1,360
Dependence of Reaction Velocity upon surface and Agitation
Hixson, A. W., & Crowell, J. H. (1931) · Industrial & Engineering Chemistry · doi:10.1021/ie50260a018 · Cited by 1,176
Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery
Rapoport, N. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.009 · Cited by 1,002
Gan, Q., Wang, T., Cochrane, C., & McCarron, P. (2005) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2005.06.001 · Cited by 908
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Chitosan nanoparticles as delivery systems for doxorubicin
Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00294-2 · Cited by 721
Gan, Q., & Wang, T. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.04.009 · Cited by 711
Natural Polymers for Gene Delivery and Tissue Engineering
DANG, J., & LEONG, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.001 · Cited by 694
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Development and characterisation of chitosan nanoparticles for siRNA delivery
Katas, H., & Alpar, H. O. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.021 · Cited by 642
Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior
López-León, T., Carvalho, E. L. S., Seijo, B., Ortega-Vinuesa, J. L., & Bastos-González, D. (2005) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.08.186 · Cited by 444
Zhang, J. L., Srivastava, R. S., & Misra, R. D. K. (2007) · Langmuir · doi:10.1021/la0636199 · Cited by 433
Csaba, N., Köping-Höggård, M., & Alonso, M. J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.028 · Cited by 307
Role of Nanotechnology in Pharmaceutical Product Development
Devalapally, H., Chakilam, A., & Amiji, M. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20875 · Cited by 230
Lim, E., Huh, Y., Yang, J., Lee, K., Suh, J., & Haam, S. (2011) · Advanced Materials · doi:10.1002/adma.201100351 · Cited by 220
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Self-Assembled Hydrogel Nanoparticles for Drug Delivery Applications
Gonçalves, C., Pereira, P., & Gama, M. (2010) · Materials · doi:10.3390/ma3021420 · Cited by 193
Chitosan, a drug carrier for the 21st century: a review
Paul, W., & Sharma, C. P. (2000) · Stp Pharma Sciences · Cited by 184
Quantitative Calculations in Pharmaceutical Practice and Research
Chatzēiōannou, T. P., Christian, G. D., Koupparis, M. Α., & Macheras, P. E. (1993) · Cited by 125
Preparation and Characterization of the Fluorescent Chitosan Nanoparticle Probe
Zhao, J., & Wu, J. (2006) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(07)60015-2 · Cited by 73
Bourne, D. W. A. (2002) · Drugs and the pharmaceutical sciences · doi:10.1201/9780824744694.ch3 · Cited by 39
Iontophoresis of 5-fluorouracil into the conjunctiva and sclera.
Kondo, M., & Araie, M. (1989) · PubMed · Cited by 22
Improvement of processability of poly(?-caprolactone) by radiation techniques
Darwis, D., Nishimura, K. J., Mitomo, H., & Yoshii, F. (1999) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19991114)74:7<1868::aid-app32>3.0.co;2-n · Cited by 16
Cited by
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Lengyel, M., Kállai-Szabó, N., Antal, V., Laki, A. J., & Antal, I. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87030020 · Cited by 598
Unsoy, G., Khodadust, R., Yalcin, S., Mutlu, P., & Gunduz, U. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.021 · Cited by 333
Bagre, A. P., Jain, K., & Jain, N. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.037 · Cited by 266
Nano drug delivery strategy of 5-fluorouracil for the treatment of colorectal cancer
Chandran, S. P., Natarajan, S. B., Chandraseharan, S., & Mohd Shahimi, M. S. B. (2017) · Journal of Cancer Research and Practice · doi:10.1016/j.jcrpr.2017.02.002 · Cited by 97
Yu, Y., Chen, D., Li, Y., Yang, W., Tu, J., & Shen, Y. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1458923 · Cited by 85
Metadata
- Authors
- Tığlı Aydın, R. S., & Pulat, M.
- Venue
- Journal of Nanomaterials
- Publisher
- Wiley
- Published
- 2012-01
- Volume
- 2012
- Issue
- 1
- ISSN
- 1687-4110 (ISSN-L)
- 1687-4129
- OpenAlex
- W2079479950
- Cited by
- 324
- References
- 30
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.